MISSISSAUGA, Ontario — Valeant Pharmaceuticals on Thursday announced the resignation of Michael Van Every from its board of directors.
The company said Van Every, who has served on the board since 2004, resigned due to health reasons.
"We want to thank Michael for his many years of service to the company, first at Biovail and then, following the merger of Biovail and Valeant, as part of the new Valeant board," Valeant chairman and CEO J. Michael Pearson said. "Michael's accounting expertise was a tremendous asset to company and brought a much needed stability to the financial organization during his tenure as head of the finance and audit committee. Michael's counsel will be missed and we wish him well in his recovery."